# Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population

> **NCT00071448** · PHASE3 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 378 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** insulin human
- **DRUG:** insulin lispro
- **DRUG:** insulin aspart

## Key facts

- **NCT ID:** NCT00071448
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** 2004-06
- **Final completion:** 2004-06
- **Target enrollment:** 378 (ACTUAL)
- **Last updated:** 2016-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00071448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00071448, "Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00071448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*